Kronox Lab Sciences Ltd Falls 0.75% This Week: 6-Day Downtrend and Valuation Concerns

1 hour ago
share
Share Via
Kronox Lab Sciences Ltd’s stock closed the week at Rs.119.10, down 0.75% from the previous Friday’s close of Rs.120.00, marginally outperforming the Sensex which fell 0.96% over the same period. The week was marked by a sustained downtrend with the stock hitting fresh 52-week and all-time lows amid mixed financial results and persistent valuation concerns.

Key Events This Week

23 Feb: Stock opens week at Rs.119.15, down 0.71%

24 Feb: New 52-week and all-time low of Rs.116.75 amid market downturn

25 Feb: Further decline to Rs.115, extending six-day losing streak

26 Feb: Sharp rebound to Rs.118.35 (+5.29%) on increased volume

27 Feb: Week closes at Rs.119.10, slight gain of 0.63% on the day

Week Open
Rs.120.00
Week Close
Rs.119.10
-0.75%
Week Low
Rs.115.00
vs Sensex
+0.21%

Monday, 23 February 2026: Modest Decline Amid Positive Market

Kronox Lab Sciences Ltd began the week at Rs.119.15, down 0.71% from the previous close of Rs.120.00. This decline contrasted with the Sensex’s gain of 0.39% to 36,817.86, signalling early weakness in the stock despite a broadly positive market environment. The volume was relatively low at 677 shares, indicating subdued trading interest.

Tuesday, 24 February 2026: Stock Hits 52-Week and All-Time Low

The stock fell sharply to a new 52-week and all-time low of Rs.116.75, closing the day at Rs.117.95, down 1.01%. This decline was more pronounced than the Sensex’s 0.78% drop to 36,530.09, reflecting company-specific pressures amid a broader market downturn. The stock has been on a five-day losing streak entering this day, cumulatively down 4.64% over that period.

Fundamental concerns weighed on sentiment, including flat quarterly results for December 2025 and modest long-term sales growth of 6.80% CAGR over five years. Despite a strong return on equity of 28.7%, the stock’s valuation remains expensive with a price-to-book ratio near 4.9, which may have contributed to the negative momentum.

Wednesday, 25 February 2026: Continued Downtrend to Rs.115

Kronox Lab Sciences Ltd extended its decline to Rs.115, marking the lowest price of the week and a fresh all-time low. The stock closed down 1.99% on the day, underperforming the Sensex which gained 0.41%. This day marked the sixth consecutive session of losses, with a cumulative decline of nearly 5.9% over that span.

Technical indicators remained bearish, with the stock trading below all major moving averages (5-day through 200-day), signalling sustained downward momentum. The company’s conservative capital structure, with zero debt-to-equity ratio, and promoter majority ownership have not been sufficient to arrest the price decline amid flat recent results and valuation concerns.

Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!

  • - Long-term growth stock
  • - Multi-quarter performance
  • - Sustainable gains ahead

Invest for the Long Haul →

Thursday, 26 February 2026: Sharp Rebound on Increased Volume

After a prolonged downtrend, the stock rebounded strongly to Rs.118.35, gaining 5.29% on the day with volume surging to 3,375 shares. This recovery contrasted with the Sensex’s modest 0.19% gain, suggesting some bargain hunting or short-term technical buying in Kronox Lab Sciences Ltd.

Despite this bounce, the stock remains well below its 52-week high of Rs.207.40 and continues to trade below all key moving averages. The rebound may reflect temporary relief rather than a reversal of the prevailing downtrend, given the company’s flat recent financial results and ongoing valuation challenges.

Friday, 27 February 2026: Week Closes Slightly Lower Amid Market Weakness

The stock closed the week at Rs.119.10, up 0.63% on the day but still down 0.75% for the week. This slight gain came despite the Sensex falling 1.16% to 36,322.56, indicating relative resilience in Kronox Lab Sciences Ltd’s price on the final trading day. Volume increased further to 3,489 shares, suggesting sustained investor interest despite the negative weekly performance.

Overall, the stock’s performance this week highlights a challenging environment with persistent downward pressure offset by intermittent rebounds. The company’s strong return on equity and debt-free balance sheet provide some fundamental support, but flat sales growth and valuation concerns continue to weigh on the share price.

Holding Kronox Lab Sciences Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Weekly Price Performance: Kronox Lab Sciences Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-02-23 Rs.119.15 -0.71% 36,817.86 +0.39%
2026-02-24 Rs.117.95 -1.01% 36,530.09 -0.78%
2026-02-25 Rs.112.40 -4.71% 36,679.75 +0.41%
2026-02-26 Rs.118.35 +5.29% 36,748.49 +0.19%
2026-02-27 Rs.119.10 +0.63% 36,322.56 -1.16%

Key Takeaways

Persistent Downtrend: The stock experienced a six-day losing streak culminating in a 52-week and all-time low of Rs.115 on 25 February, reflecting sustained bearish momentum and investor caution.

Valuation and Profitability: Despite a high return on equity of 28.7% and a debt-free balance sheet, the stock trades at a relatively expensive price-to-book ratio near 4.8-4.9, which may be limiting upside potential amid flat recent sales growth.

Mixed Market Context: The stock underperformed the Sensex on most days but showed resilience with a sharp rebound on 26 February and a slight gain on the final trading day, indicating some short-term buying interest.

Technical Weakness: Trading below all major moving averages signals ongoing downward pressure, suggesting that the stock remains in a corrective phase despite intermittent rallies.

Conclusion

Kronox Lab Sciences Ltd’s performance this week highlights the challenges faced by the stock amid a difficult market environment and company-specific concerns. The stock’s decline to fresh lows contrasts with the broader market’s mixed performance, underscoring persistent valuation and growth questions despite strong profitability metrics. While the rebound on 26 February offered some relief, the overall trend remains negative with technical indicators pointing to continued caution. Investors should monitor upcoming financial results and market developments closely to assess any change in momentum.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
BMW Industries Ltd is Rated Sell
38 minutes ago
share
Share Via
Jubilant Ingrevia Ltd is Rated Strong Sell
38 minutes ago
share
Share Via
Ugar Sugar Works Ltd. is Rated Sell
38 minutes ago
share
Share Via
Plastiblends India Ltd is Rated Strong Sell
38 minutes ago
share
Share Via